13F Holdings
中文EN

MDNC Medinotec Inc.

Surgical & Medical Instruments & Apparatus · OTC · SEC CIK 1931055 · Fiscal year ends 02/28

Financial factors as of 2026-08-31 (2027Q2), TTM = sum of the last four quarters

Growth

TTM revenue YoY-10.9%
TTM net income YoY-73.4%
TTM EPS YoY-73.4%
Revenue 3-yr CAGR92.4%
Net income 3-yr CAGR—

Margins

Gross margin49.6%
Operating margin6.6%
Net margin5.8%
FCF margin—
EBITDA margin7.6%

Returns

ROE11.1%
ROA9.0%
ROIC (approx.)22.6%
Asset turnover1.53x

Leverage & solvency

Liabilities / assets14.7%
Debt / equity0.00x
Current ratio6.74x
Interest coverage21.76x

Cash quality & payout

Operating cash flow / net income0.63x
Accruals ratio3.3%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20262026-02-28FY20252025-02-28FY20242024-02-29FY20232023-02-28
Income statement
Revenue$9.73M$9.11M$5.02M$999,579
Cost of revenue$4.60M$4.30M-$2.58M-$417,757
Gross profit$5.13M$4.82M$2.44M$581,822
R&D expense$149,858$91,133-$22,351-$64,866
SG&A expense$2.32M$1.35M-$1.67M-$648,172
Operating income$1.09M$3.19M$600,578-$238,587
Interest expense$87,595$176,416-$277,230-$226,814
Pretax income$1.07M$3.02M-$253,770-$391,477
Income tax-$274,685-$864,665-$150,918$38,742
Net income$794,502$2.16M-$404,688-$352,735
EBITDA$1.18M$3.27M$688,803-$185,034
EPS (basic)0.070.18-0.03-0.03
EPS (diluted)————
Banking
Loans, net———$605,130
Balance sheet
Cash & equivalents$2.76M$2.77M$2.81M$2.83M
Receivables$2.35M$2.61M$589,761$21,074
Inventory$1.24M$988,341$863,452$354,304
Current assets$6.42M$6.42M$4.38M$3.37M
PP&E, net$331,346$348,486$320,122$406,873
Total assets$6.81M$6.81M$4.80M$4.49M
Current liabilities$1.10M$1.51M$827,453$71,311
Total liabilities$1.10M$2.54M$2.64M$1.93M
Shareholders' equity$5.71M$4.27M$2.17M$2.56M
Shares outstanding11.76M11.73M11.73M11,734
Cash flow statement
Operating cash flow$906,798$877,834$14,242-$490,549
Capital expenditure$1,363$89,013-$2,255$55,277
Free cash flow$905,435$788,821$16,497-$545,826
Investing cash flow-$1,363-$89,013$10,125-$529,723
Financing cash flow-$982,973-$894,482-$8,092$3.58M
Depreciation & amortization$80,873$73,846$88,225$53,553

· This company reports EPS only by share class (e.g. class A/B), so it is shown as —.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.